Trial Profile
Prospective Observational Post-Authorisation Study on the Use of Bemfola in Human Assisted Reproductive Technology
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Follitropin alfa (Primary)
- Indications Infertility
- Focus Therapeutic Use
- Sponsors Finox Biotech
- 04 Feb 2020 Status changed from recruiting to completed.
- 06 Feb 2018 Planned end date changed from 1 Jan 2018 to 1 Jan 2019.
- 06 Feb 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Aug 2018.